Product Overview
Vedolizumab | T9914 | TargetMol Chemicals
CAS: 943609-66-3
Smiles:
Formula: N/A
Pathway: Cytoskeletal Signaling
Target: Integrin
Receptor: N/A
Bioactivity: Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
Molecular Weight: N/A